Inovio Pharmaceuticals, Inc (INO). - Quick study

Intro:


While doing some research on what stocks to buy, I came up with this stock recommended by Jim Crammer (thru one of the youtube videos posted by CNBC).  

"Inovio Pharmaceuticals Inc is a late-stage biotechnology company.  It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines.  The firm's drug candidates include SynCon immunotherapies which help break the immune system's tolerance of cancerous cells; the CELLECTRA delivery system facilitates optimized cellular uptake of the SynCon immunotherapies."

The company was founded by David B. Weiner on June 29, 1983, and is headquartered in Plymouth Meeting, PA.

"On April 24, 2020, the company's Chief Executive Joseph Kim said his company's COVID-19 vaccine study backed by the Bill and Melinda Gates Foundation is expected to complete patient enrollment by the end of April.  The study will enroll 40 volunteers who were screened at a medical center in Kansas City, MO.   Volunteers will be administered with the INO-4800 vaccine four weeks apart."

Having said this, my friend has lost lot of money on Pharmaceuticals based companies.  He is saying that some Doctors or Bio medical-based persons can just spawn some companies claiming they have medicines and formula for COVID-19 and just pump up the stocks and then abscond.

Place your hard-earned money after doing good research.

References: Merrill Lynch.  

Comments

Popular posts from this blog

Why I like “Diary” Program in Hello FM 106.4

Indian Police Cop

Avatar